OPTIMIZED ANTI-TL1A ANTIBODIES
- 专利权人:
- Prometheus Biosciences; Inc.
- 发明人:
- Jeffry D. Watkins,Cindy T. Dickerson,J. Monty Watkins
- 申请号：
- US16863971
- 公开号：
- US20200255510A1
- 申请日:
- 2020.04.30
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Optimized anti-TL1A antibodies
- Estra-1,3,5 (10), 16-tetraene-3-carboxamide derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
- ПРИМЕНЕНИЕ АНТИТЕЛА К CD151 ДЛЯ ЛЕЧЕНИЯ РАКА
- קומבינציות ושימושיהן
- АНТИ-НЕR2 АНТИТЕЛО И ЕГО КОНЪЮГАТ
